BioSpace News Archive

Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced the appointment of Paul Patrizio as Strategic Advisor to the Propanc Executive team.

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, November 10, 2021, 4:30 p.m. ET

Rapid Medical today announced FDA investigational device exemption (IDE) approval for the first-ever trial to expand interventional stroke treatment to distal regions of the brain.

Ainos, Inc., announced that the company has recently achieved early stage milestones in its mRNA vaccine research and development initiative.

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, announced that it has expanded its board of directors from three to five and has appointed three new, independent directors.

Parthenon Therapeutics today announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures.

ReCode Therapeutics presented new preclinical data today from the Company’s inhaled mRNA-based therapeutic program for cystic fibrosis (CF) during an oral poster session at the 2021 North American Cystic Fibrosis Conference (NACFC).

TRACON Pharmaceuticals (NASDAQ:TCON), today announced financial results for the third quarter ended September 30, 2021.

Freeline Therapeutics Holdings plc announced that on October 29, 2021, the Company granted three new employees non-statutory options to purchase an aggregate of 69,800 of the Company’s ordinary shares and 4,250 restricted share units, each representing the right to receive one of the Company’s ordinary shares upon vesting.

Viridian Therapeutics, Inc. announced that Jonathan Violin, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Credit Suisse 30th Annual Healthcare Conference and participate in fireside chats at the Jefferies London Healthcare Conference and the Evercore ISI 4th Annual HealthCONx Conference.